Centalun

Source: Wikipedia, the free encyclopedia.
Centalun
Clinical data
ATC code
  • none
Legal status
Legal status
  • In general: unscheduled
Identifiers
  • 2-methyl-1-phenylbut-3-yne-1,2-diol
JSmol)
  • OC(c1ccccc1)C(C#C)(O)C
  • InChI=1S/C11H12O2/c1-3-11(2,13)10(12)9-7-5-4-6-8-9/h1,4-8,10,12-13H,2H3 ☒N
  • Key:GQOXDWHRXDPZJK-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Centalun was developed by Boehringer Ingelheim in 1962

CSA
and therefore remains unregulated as a drug of abuse.

References

  1. ^ BE 618130, "Procédé pour l'obtention d'alkinediols" 
  2. S2CID 144088161
    .
  3. PMID 14238754
    .
  4. PMID 14243120
    .
  5. PMID 14193290
    .
Stub icon

This sedative-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Centalun&oldid=1136444545"